Group structure
6 companies in 2 countries
United States1
Headquarters not stated3
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Loading your page…
Loading your page…
6 companies in 2 countries
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine of every company in the group, current ones first.
1–25 of 99
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACTONEL WITH CALCIUM (COPACKAGED)500MG BASE; 35MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Carbonate, Risedronate | United States | Not marketed | 2005 |
| AMITRIL100mg | 10mg | 150mg | 25mg | 50mg | 75mg · Tablet | Amitriptyline | United States | Not marketed | |
| CHOLEDYL SA400mg | 600mg · Tablet, extended release | Choline theophyllinate | United States | Not marketed | 1981 |
| CYCLOPAR250mg | 500mg · Capsule | Tetracycline | United States | Not marketed | 1973 |
| DOPAMINE HYDROCHLORIDE160mg/100ml | 160mg/ml | 40mg/ml | 80mg/100ml | 80mg/ml · Injectable | Dopamine | United States | Marketed | 1981 |
| DURAQUIN330mg · Tablet, extended release | Quinidine | United States | Not marketed | |
| DURICEF1GM BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Cefadroxil | United States | Not marketed | 1980 |
| DURICEF250MG BASE | 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Capsule | Cefadroxil | United States | Not marketed | 1978 |
| DURICEF125MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 250MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 500MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons · For suspension | Cefadroxil | United States | Not marketed | 1980 |
| ERYC250mg · Capsule, delayed rel pellets | Erythromycin | United States | Marketed | 1981 |
| ERYPAR250mg base | 500mg base · Tablet | Erythromycin | United States | Not marketed | 1977 |
| HEAD & SHOULDERS CONDITIONER0.3% · Lotion | Pyrithione zinc | United States | Not marketed | |
| IDEOS UNIDIA 1000 MG/880 UI GRANULADO EFERVESCENTE2500 mg + 880 UI · Granulado efervescente | Carbonate, Vitamin d | Spain | Authorised | 2018 |
| LABID250mg · Tablet, extended release | Theophylline | United States | Not marketed | |
| NYSERT100,000 units · Suppository | Nystatin | United States | Not marketed | |
| ORLEX2% · Solution/drops | Acetic acid, Glacial | United States | Not marketed | 1979 |
| ORLEX HC2%; 1% · Solution/drops | Acetic acid, Glacial, Hydrocortisone | United States | Not marketed | 1980 |
| OVCON-350.035MG; 0.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 1978 |
| OVCON-350.035MG; 0.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 1976 |
| OVCON-500.05MG; 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 1975 |
| OVCON-500.05mg; 1mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 1978 |
| PROPOXYPHENE HYDROCHLORIDE 6565mg · Capsule | Propoxyphene | United States | Not marketed | |
| PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE25mg; 40mg | 25mg; 80mg · Tablet | Hydrochlorothiazide, Propranolol | United States | Not marketed | 1986 |
| SPIRONOLACTONE100mg | 25mg | 50mg · Tablet | Spironolactone | United States | Marketed | 1980 |
| VERAPAMIL HYDROCHLORIDE120mg | 40mg | 80mg · Tablet | Verapamil | United States | Marketed | 1986 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 71 | 0 | 71 | CompaniesAll medicines |
| United States | 25 | 25 | 0 | CompaniesAll medicines |
| European Union (EMA) | 2 | 0 | 2 | CompaniesAll medicines |
| Spain | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of Brazil
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.